Human CD20 (Research Grade Ocrelizumab Biosimilar) Alexa Fluor® 532-conjugated Antibody
Human CD20 (Research Grade Ocrelizumab Biosimilar) Alexa Fluor® 532-conjugated Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
Background: CD20
Ocrelizumab is an anti-human CD20 antibody used for the treatment of advanced or relapsing multiple sclerosis. It is a humanized recombinant anti human CD20 antibody, and is used to specifically deplete B-cells. A proposed pharmacological mechanism of action is that the antibody most likely binds to the B-cell surface CD20 resulting in antibody-dependent cellular cytotoxicity and complement-mediated cell lysis, but does not impact B-cell reconstitution and preexisting humoral immunity.
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CD20 (Research Grade Ocrelizumab Biosimilar) Alexa Fluor® 532-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human CD20 (Research Grade Ocrelizumab Biosimilar) Alexa Fluor® 532-conjugated Antibody and earn rewards!
Have you used Human CD20 (Research Grade Ocrelizumab Biosimilar) Alexa Fluor® 532-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
